News

Dr. Thomas Koch and Dr. Harrison Barrett are being honored as National Academy of Inventors Fellows, which is the highest professional distinction awarded to academic inventors.

Download the FY2018 Annual Report and review our progress against our vision and goals, and learn more about how the culture of commercialization is growing throughout the University of Arizona ecosystem.

At the 2018 Governor’s Celebration of Innovation in Phoenix, this year’s finalists included three impactful University of Arizona-associated companies and inventors, two of which went on to be selected as winners.

From Kazakh to Kurmanji Kurdish, Language Canvas is making UA-developed learning programs for less commonly taught languages available to people everywhere.

How can farmers of aquatic animals quickly select the best stocks for breeding? Benjamin Renquist, PhD, answered this challenge by inventing an assay that works for fish, mollusks and crustaceans alike. The technology has been licensed to startup GenetiRate.

On October 3 and 4, 2018, in Phoenix, Arizona, White Hat Investors will be holding its annual luncheon. Of the 32 companies who will be presenting during the two-day event, five are UA startups.

After thirty-two years of working for the University of Arizona, Associate Vice President Bruce A. Wright, who brought a new tech-based vision for the economy to the University and our community is retiring from Tech Parks Arizona.

UA inventors have developed a system that interviews border crossers, monitors thousands of signals from the voice, body and eyes, and alerts agents when it detects deception. Meet the AVATAR, now licensed to Discern Science International, Inc.

For FY2018, the UA has again met or surpassed performance expectations for technology commercialization as TLA continues to bring University inventions from the lab to the world for social and economic benefit. Now, it's time to look forward.

Tucson's newest early-stage capital fund, UA Venture Capital Fund LLC, has announced that it's first investments will be in three UA-connected companies: startups Codelucida, Regulonix and Post.Bid.Ship.

As cancer diagnostics and therapeutics become more personalized, pathologists will require more high-quality tissue from biopsies for testing. To address the challenge, this startup is working to bring a next-generation biopsy instrument invented at the UA to the world.

Over 3 million new cases of skin cancer are diagnosed annually, but we have a natural defense against cancer-causing UV rays: melanin. Now, the UA has licensed two melanin-producing peptides to startup MCR Therapeutics.